These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36769775)

  • 1. Effectiveness, Safety and Choroidal Changes of a Fovea-Sparing Technique for the Treatment of Chronic Central Serous Chorioretinopathy with Yellow Subthreshold Laser.
    Torrellas B; Filloy A; Wu L; Chhablani J; Romero-Aroca P
    J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of Retinal Microsecond Pulse Laser Treatment in Central Serous Chorioretinopathy: A Short-Term Optical Coherence Tomography Angiography Study.
    Prasuhn M; Miura Y; Tura A; Rommel F; Kakkassery V; Sonntag S; Grisanti S; Ranjbar M
    J Clin Med; 2021 May; 10(11):. PubMed ID: 34072472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of choriocapillaris using optical coherence tomography and optical coherence tomography angiography in patients with central serous chorioretinopathy after half-dose photodynamic therapy.
    Yang HS; Kang TG; Park H; Heo JS; Park J; Lee KS; Choi S
    PLoS One; 2020; 15(1):e0227718. PubMed ID: 31929582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy.
    Yun C; Huh J; Ahn SM; Lee B; Kim JT; Hwang SY; Kim SW; Oh J
    Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):57-70. PubMed ID: 30397792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical research on one-third dose verteporfin photodynamic therapy in the treatment of chronic central serous chorioretinopathy.
    Hua L; Lin B; Hong J; Min HB; Han WL; Zhou TY; Zhang ZQ
    Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):278-284. PubMed ID: 29424884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CHOROIDAL THICKNESS IN PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY: Assessment of Haller and Sattler Layers.
    Chung YR; Kim JW; Kim SW; Lee K
    Retina; 2016 Sep; 36(9):1652-7. PubMed ID: 26934451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the choroidal features in pachychoroid spectrum diseases by optical coherence tomography and optical coherence tomography angiography.
    Demirel S; Değirmenci MFK; Batıoğlu F; Özmert E
    Eur J Ophthalmol; 2021 Jan; 31(1):184-193. PubMed ID: 31684767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of choriocapillaris perfusion and choroidal layer changes in patients with chronic central serous chorioretinopathy randomised to micropulse laser or photodynamic therapy.
    Ho M; Lai FHP; Ng DSC; Iu LPL; Chen LJ; Mak ACY; Yip Y; Cheung C; Young AL; Brelen M
    Br J Ophthalmol; 2021 Apr; 105(4):555-560. PubMed ID: 32532761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EN FACE IMAGING OF PACHYCHOROID SPECTRUM DISORDERS WITH SWEPT-SOURCE OPTICAL COHERENCE TOMOGRAPHY.
    Dansingani KK; Balaratnasingam C; Naysan J; Freund KB
    Retina; 2016 Mar; 36(3):499-516. PubMed ID: 26335436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
    Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
    Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy.
    Schworm B; Siedlecki J; Keidel LF; Herold TR; Luft N; Priglinger SG
    Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3271-3281. PubMed ID: 34110452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Choroid after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy.
    Christou EE; Katsanos A; Georgalas I; Kozobolis V; Kalogeropoulos C; Stefaniotou M
    Acta Medica (Hradec Kralove); 2022; 65(3):89-98. PubMed ID: 36735886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic filling delay of the choriocapillaris in the region of dilated asymmetric vortex veins in central serous chorioretinopathy.
    Kishi S; Matsumoto H; Sonoda S; Hiroe T; Sakamoto T; Akiyama H
    PLoS One; 2018; 13(11):e0206646. PubMed ID: 30412594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CHANGES IN CHORIOCAPILLARIS, SATTLER, AND HALLER LAYER THICKNESSES IN CENTRAL SEROUS CHORIORETINOPATHY AFTER HALF-FLUENCE PHOTODYNAMIC THERAPY.
    Flores-Moreno I; Arcos-Villegas G; Sastre M; Ruiz-Medrano J; Arias-Barquet L; Duker JS; Ruiz-Moreno JM
    Retina; 2020 Dec; 40(12):2373-2378. PubMed ID: 31985718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography.
    Yang J; Wang E; Yuan M; Chen Y
    Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):241-247. PubMed ID: 31724090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional choroidal vascularity index in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography angiography.
    Zeng Q; Luo L; Yao Y; Tu S; Yang Z; Zhao M
    Front Med (Lausanne); 2022; 9():967369. PubMed ID: 36160148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impairment of visual acuity and retinal morphology following resolved chronic central serous chorioretinopathy.
    Gawęcki M; Jaszczuk-Maciejewska A; Jurska-Jaśko A; Kneba M; Grzybowski A
    BMC Ophthalmol; 2019 Jul; 19(1):160. PubMed ID: 31345183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year follow-up of choroidal and macular thickness in acute non-treated central serous chorioretinopathy.
    Orduña-Azcona J; Pérez-Fernández E; Modamio L; De Manuel-Triantafilo S; Rodríguez-Hernández CF; Gili P
    Clin Exp Optom; 2023 Jan; 106(1):47-55. PubMed ID: 35157808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy.
    Uzlu D; Erdöl H; Kola M; Özbay AD
    Lasers Med Sci; 2021 Jul; 36(5):981-988. PubMed ID: 32812130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy.
    Beniwal A; Shaikh N; Chawla R; Azad SV; Kumar V; Vohra R
    Indian J Ophthalmol; 2022 Sep; 70(9):3341-3345. PubMed ID: 36018117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.